UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Cancer, ISSN 0008-543X, 12/2014, Volume 120, Issue 23, pp. 3660 - 3668
Augmented Berlin-Frankfurt-Munster | Pediatric-based regimens | Acute lymphoblastic leukemia | Pediatric-based therapy | Philadelphia chromosome-negative ALL | Life Sciences & Biomedicine | Oncology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Tumors | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | Humans | Induction Chemotherapy | Male | Consolidation Chemotherapy | Young Adult | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Vincristine - administration & dosage | Adult | Female | Maintenance Chemotherapy | Daunorubicin - administration & dosage | Doxorubicin - administration & dosage | Dexamethasone - administration & dosage | Mercaptopurine - administration & dosage | Treatment Outcome | Cytarabine - administration & dosage | Asparaginase - administration & dosage | Thioguanine - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Methotrexate - administration & dosage | Cohort Studies | Index Medicus | Abridged Index Medicus
Journal Article
Cancer, ISSN 0008-543X, 01/2015, Volume 121, Issue 2, pp. 234 - 242
Phase II | Chemotherapy Intervention | Acute Myeloid Leukemia | First Relapse | Acute myeloid leukemia | First relapse | Chemotherapy intervention | Life Sciences & Biomedicine | Oncology | Science & Technology | Recurrence | Mitoxantrone - administration & dosage | Humans | Middle Aged | Male | Antibodies, Monoclonal, Humanized - administration & dosage | Aminoglycosides - administration & dosage | Leukemia, Myeloid, Acute - drug therapy | Adult | Female | Daunorubicin - administration & dosage | Risk Assessment | Kaplan-Meier Estimate | Etoposide - administration & dosage | Treatment Outcome | Amsacrine - administration & dosage | Vidarabine - analogs & derivatives | Remission Induction | Cytarabine - administration & dosage | Cladribine - administration & dosage | Leukemia, Myeloid, Acute - mortality | Disease-Free Survival | Injections | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Vidarabine - administration & dosage | Liposomes | Salvage Therapy - methods | Chemotherapy | Usage | Health aspects | Patient outcomes | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Blood, ISSN 0006-4971, 11/2010, Volume 116, Issue 19, pp. 3751 - 3757
Life Sciences & Biomedicine | Hematology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Tretinoin - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Mercaptopurine - administration & dosage | Male | Treatment Outcome | North America | Cytarabine - administration & dosage | Young Adult | Disease-Free Survival | Arsenicals - administration & dosage | Adolescent | Leukemia, Promyelocytic, Acute - mortality | Survival Analysis | Adult | Female | Methotrexate - administration & dosage | Aged | Daunorubicin - administration & dosage | Oxides - administration & dosage | Leukemia, Promyelocytic, Acute - drug therapy | Index Medicus | Abridged Index Medicus | Clinical Trials and Observations
Journal Article
The New England journal of medicine, ISSN 0028-4793, 09/2009, Volume 361, Issue 13, pp. 1235 - 1248
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | General aspects | Medical sciences | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Age Factors | Humans | Middle Aged | Antibiotics, Antineoplastic - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Leukemia, Myelomonocytic, Acute - drug therapy | Stem Cell Transplantation | Antibodies, Monoclonal, Humanized | Leukemia, Myelomonocytic, Acute - therapy | Aminoglycosides - administration & dosage | Aged, 80 and over | Female | Remission Induction - methods | Daunorubicin - administration & dosage | Proportional Hazards Models | Combined Modality Therapy | Cytarabine - administration & dosage | Daunorubicin - adverse effects | Antibiotics, Antineoplastic - administration & dosage | Antibodies, Monoclonal - administration & dosage | Survival Analysis | Aged | Infusions, Intravenous | Leukemia, Myelomonocytic, Acute - mortality | Aged patients | Usage | Dosage and administration | Daunorubicin | Health aspects | Medical treatment | Leukemia | Age | Index Medicus | Abridged Index Medicus
Journal Article
Pediatric blood & cancer, ISSN 1545-5009, 03/2007, Volume 48, Issue 3, pp. 254 - 261
adolescent | young adult | acute lymphoblastic leukemia | treatment outcome | survival | Treatment outcome | Acute lymphoblastic leukemia | Survival | Adolescent | Young adult | Pediatrics | Oncology | Life Sciences & Biomedicine | Hematology | Science & Technology | Cyclophosphamide - administration & dosage | Prednisolone - administration & dosage | Prognosis | Age Factors | Humans | Male | Transplantation, Autologous | Transplantation, Homologous | Patient Selection | Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy | Bone Marrow Transplantation | Vincristine - administration & dosage | Female | Daunorubicin - administration & dosage | Randomized Controlled Trials as Topic - statistics & numerical data | Dexamethasone - administration & dosage | Mercaptopurine - administration & dosage | Etoposide - administration & dosage | Treatment Outcome | Combined Modality Therapy | Cranial Irradiation | Remission Induction | Cytarabine - administration & dosage | Asparaginase - administration & dosage | Disease-Free Survival | Thioguanine - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Methotrexate - administration & dosage | Research Design | Index Medicus
Journal Article
Leukemia, ISSN 0887-6924, 08/2017, Volume 31, Issue 8, pp. 1840 - 1842
Oncology | Life Sciences & Biomedicine | Hematology | Science & Technology | Cyclophosphamide - administration & dosage | Prednisone - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Dexamethasone - administration & dosage | Humans | Mercaptopurine - administration & dosage | Child, Preschool | Treatment Outcome | Cytarabine - administration & dosage | Asparaginase - administration & dosage | Ikaros Transcription Factor - genetics | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Gene Deletion | Adolescent | Vincristine - administration & dosage | Methotrexate - administration & dosage | Child | Daunorubicin - administration & dosage | Dexamethasone | Acute lymphatic leukemia | Children | Lymphatic leukemia | Vincristine | Leukemia | Index Medicus
Journal Article
The lancet oncology, ISSN 1470-2045, 2012, Volume 13, Issue 9, pp. 906 - 915
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Osteonecrosis - epidemiology | Humans | Child, Preschool | Dexamethasone - adverse effects | Infant | Male | Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality | Incidence | Young Adult | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Vincristine - administration & dosage | Female | Child | Daunorubicin - administration & dosage | Osteonecrosis - diagnosis | Prednisone - administration & dosage | Dexamethasone - administration & dosage | Drug Administration Schedule | Survival Rate | Treatment Outcome | Cytarabine - administration & dosage | Asparaginase - administration & dosage | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Sex Factors | Sex Distribution | Methotrexate - administration & dosage | Osteonecrosis - chemically induced | Osteonecrosis - prevention & control | Cohort Studies | Pediatrics | Hunger | Dexamethasone | Bones | Public health | Necrosis | Steroids | Index Medicus
Journal Article
Journal of pediatric hematology/oncology, ISSN 1077-4114, 2017, Volume 39, Issue 2, pp. 81 - 89
clinical trial | childhood | acute lymphoblastic leukemia | Pediatrics | Oncology | Life Sciences & Biomedicine | Hematology | Science & Technology | Japan - epidemiology | Cyclophosphamide - administration & dosage | Prednisolone - administration & dosage | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Child, Preschool | Infant | Male | Risk | Consolidation Chemotherapy | Hydrocortisone - administration & dosage | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - mortality | Doxorubicin - analogs & derivatives | Vincristine - administration & dosage | Female | Maintenance Chemotherapy | Child | Daunorubicin - administration & dosage | Doxorubicin - administration & dosage | Dexamethasone - administration & dosage | Mercaptopurine - administration & dosage | Survival Rate | Treatment Outcome | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - radiotherapy | Cranial Irradiation | Remission Induction | Cytarabine - administration & dosage | Daunorubicin - adverse effects | Asparaginase - administration & dosage | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Methotrexate - administration & dosage | Doxorubicin - adverse effects | Index Medicus
Journal Article
Blood, ISSN 0006-4971, 05/2014, Volume 123, Issue 21, pp. 3239 - 3246
Life Sciences & Biomedicine | Hematology | Science & Technology | Daunorubicin - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Cytarabine - therapeutic use | Humans | Middle Aged | Antibiotics, Antineoplastic - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cytarabine - adverse effects | Cytarabine - administration & dosage | Antimetabolites, Antineoplastic - administration & dosage | Daunorubicin - adverse effects | Antibiotics, Antineoplastic - administration & dosage | Disease-Free Survival | Antimetabolites, Antineoplastic - therapeutic use | Antibiotics, Antineoplastic - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Antimetabolites, Antineoplastic - adverse effects | Leukemia, Myeloid, Acute - drug therapy | Female | Aged | Liposomes | Daunorubicin - administration & dosage | Index Medicus | Abridged Index Medicus | 33 | 8 | Clinical Trials and Observations | 29
Journal Article
Journal of controlled release, ISSN 0168-3659, 11/2012, Volume 163, Issue 3, pp. 304 - 314
Drug delivery | Daunorubicin | Oxaliplatin | Combination chemotherapy | Polymer conjugates | Pharmacology & Pharmacy | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Multidisciplinary | Science & Technology | Biological and medical sciences | General aspects | Medical sciences | Antineoplastic agents | Pharmacology. Drug treatments | Prodrugs - administration & dosage | Cell Survival - drug effects | Polymers - administration & dosage | Organoplatinum Compounds - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Micelles | Cell Line, Tumor | Drug Carriers - administration & dosage | Antineoplastic Agents - administration & dosage | Daunorubicin - administration & dosage | Drugs | Care and treatment | Drug delivery systems | Oxalic acid | Drug therapy, Combination | Polymer industry | Polymers | Cancer | Vehicles | Index Medicus
Journal Article